Legal Probe into $LEG, $AVNS, $SEM, $GRTX M&A Deals Raises Fairness Questions

Halper Sadeh LLC, a prominent investor rights law firm, has launched formal investigations into four publicly traded companies over concerns that shareholders may not be receiving fair consideration in proposed merger and acquisition transactions. The firm is examining Leggett & Platt ($LEG), Avanos Medical ($AVNS), Select Medical Holdings ($SEM), and Galera Therapeutics ($GRTX) for potential securities law violations and breaches of fiduciary duty. At the heart of the inquiry lies a troubling pattern: insiders at these companies may be positioned to receive substantial benefits that are unavailable to ordinary shareholders, raising fundamental questions about deal fairness and board oversight.

This development underscores growing scrutiny of M&A transactions in the current market environment, where investor protection advocates are increasingly challenging the processes by which boards evaluate and negotiate major corporate transactions. The investigation signals that shareholder advocates remain vigilant about potential conflicts of interest in deals that could materially affect shareholder value.

The Specifics of the Investigation

Halper Sadeh LLC specializes in shareholder litigation and has a track record of challenging questionable corporate transactions. The firm's current investigation focuses on whether the boards of these four companies have adequately protected shareholder interests during M&A processes.

Key areas of concern in the investigation include:

• Fairness of deal consideration: Whether the proposed transaction prices adequately reflect the true economic value of the companies
• Insider conflicts: Whether company insiders, including executives and board members, stand to receive disproportionate benefits compared to public shareholders
• Fiduciary duty breaches: Whether board members have fully discharged their legal obligations to act in shareholders' best interests
• Process deficiencies: Whether proper procedures—including market checks, go-shop periods, and arm's-length negotiations—were followed

The investigation explicitly highlights that insiders may be positioned to realize substantial economic benefits from these transactions that would not be available to typical public shareholders holding equity stakes. This asymmetry is precisely the type of conflict that securities law and fiduciary duty standards are designed to prevent or remediate.

Market Context and Industry Backdrop

The timing of this investigation reflects a broader regulatory and investor environment increasingly attuned to M&A process integrity. Over the past several years, activist investors and shareholder advocacy groups have become more sophisticated in challenging transaction prices and board processes, leading to numerous settlements, deal reproposals, and enhanced governance standards.

Current M&A Market Environment:

The companies under investigation span diverse sectors—Leggett & Platt operates in furniture and bedding components, Avanos Medical focuses on healthcare delivery systems, Select Medical Holdings provides specialty healthcare services, and Galera Therapeutics develops cancer supportive care treatments. Across these industries, M&A activity has remained a key strategy for consolidation and growth, even as economic uncertainty persists.

Investor protections in M&A transactions have become increasingly sophisticated. Institutional investors, proxy advisors, and dedicated shareholder rights firms now routinely scrutinize:

• Deal pricing relative to trading multiples and peer comparisons
• Financial advisor fairness opinions and potential conflicts
• Board composition and independence
• Transaction-related executive compensation packages

The investigation by Halper Sadeh suggests that at least one of these traditional safeguards may have been insufficient for the transactions involving these four companies, or that the process itself may not have adequately protected shareholder interests.

Implications for Shareholders and Investors

For shareholders of $LEG, $AVNS, $SEM, and $GRTX, this investigation creates several important considerations:

Deal Certainty Risk: If the investigation uncovers material violations of fiduciary duty or securities law, it could result in litigation that delays or potentially enjoins the proposed transactions. Even if ultimate outcomes are uncertain, legal challenges can create months of uncertainty and administrative costs that reduce ultimate value recovery.

Valuation Concerns: The investigation's focus on whether deal consideration is "fair" suggests potential concerns that the proposed prices may not reflect true economic value. If shareholders ultimately receive settlements or modified terms due to litigation, the originally announced prices may prove to have been below fair value—a costly discovery for those who approved the deals.

Governance Expectations: This probe reinforces that public company boards face increasingly rigorous standards in M&A processes. Boards without robust independent advisors, comprehensive market checks, and transparent processes face elevated litigation risk. For institutional investors and governance-focused shareholders, this investigation exemplifies the importance of scrutinizing board processes before voting on major transactions.

Precedent and Activism: A successful investigation could incentivize additional shareholder litigation challenging other pending transactions and establish new precedent regarding what constitutes adequate fiduciary process in M&A deals.

For the broader investment community, the probe underscores that M&A transactions carrying insider conflicts or process deficiencies remain vulnerable to shareholder challenge, regardless of whether the companies are large-cap or mid-cap enterprises.

Looking Ahead

As Halper Sadeh LLC advances its investigations into $LEG, $AVNS, $SEM, and $GRTX, shareholders should monitor developments carefully. The outcomes could range from negotiated settlements that modify deal terms or pricing to formal litigation that materially impacts transaction timelines and valuations.

Ultimately, this investigation reinforces a critical principle in modern corporate finance: fair dealing matters. When boards and insiders are perceived as extracting disproportionate value from transactions, shareholder advocates and courts increasingly push back. For investors in these companies, staying informed about investigation developments is essential to understanding the true economic outcomes of these significant corporate events.